BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 15229480)

  • 21. Current status and issues in cancer stem cell study.
    Yang YM; Chang JW
    Cancer Invest; 2008 Aug; 26(7):741-55. PubMed ID: 18608212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation.
    Thimmegowda NR; Nanjunda Swamy S; Kumar CS; Kumar YC; Chandrappa S; Yip GW; Rangappa KS
    Bioorg Med Chem Lett; 2008 Jan; 18(1):432-5. PubMed ID: 17981032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human cerebrospinal fluid metabolome.
    Wishart DS; Lewis MJ; Morrissey JA; Flegel MD; Jeroncic K; Xiong Y; Cheng D; Eisner R; Gautam B; Tzur D; Sawhney S; Bamforth F; Greiner R; Li L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):164-73. PubMed ID: 18502700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer stem cell targeted agents: therapeutic approaches and consequences.
    Chumsri S; Burger AM
    Curr Opin Mol Ther; 2008 Aug; 10(4):323-33. PubMed ID: 18683096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput screening finds potential killer of cancer stem cells.
    Rowan K
    J Natl Cancer Inst; 2009 Nov; 101(21):1438-9. PubMed ID: 19828869
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of hypoxia and the metabolic microenvironment on radiotherapy of solid tumors. Introduction of a multi-institutional research project.
    Zips D; Adam M; Flentje M; Haase A; Molls M; Mueller-Klieser W; Petersen C; Philbrook C; Schmitt P; Thews O; Walenta S; Baumann M
    Strahlenther Onkol; 2004 Oct; 180(10):609-15. PubMed ID: 15480508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer stem cell markers in common cancers - therapeutic implications.
    Klonisch T; Wiechec E; Hombach-Klonisch S; Ande SR; Wesselborg S; Schulze-Osthoff K; Los M
    Trends Mol Med; 2008 Oct; 14(10):450-60. PubMed ID: 18775674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of nanotechnology for the development of novel cancer biomarkers.
    Banerjee HN; Verma M
    Expert Rev Mol Diagn; 2006 Sep; 6(5):679-83. PubMed ID: 17009903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver cancer stem cells: implications for a new therapeutic target.
    Lee TK; Castilho A; Ma S; Ng IO
    Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural analysis and Fourier transform infrared and Raman spectra of dibutoxyphosphoryl benzylisothiourea.
    Téllez S CA; De Souza V; Izolani AO
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 Sep; 60(11):2587-99. PubMed ID: 15294249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolomics applications of FT-ICR mass spectrometry.
    Brown SC; Kruppa G; Dasseux JL
    Mass Spectrom Rev; 2005; 24(2):223-31. PubMed ID: 15389859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamic biomarkers in early oncology drug development.
    Takimoto CH
    Eur J Cancer; 2009 Sep; 45 Suppl 1():436-8. PubMed ID: 19775662
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer stem cell characteristics in retinoblastoma.
    Seigel GM; Campbell LM; Narayan M; Gonzalez-Fernandez F
    Mol Vis; 2005 Sep; 11():729-37. PubMed ID: 16179903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer arises from stem cells: opportunities for anticancer drug discovery.
    López-Lázaro M
    Drug Discov Today; 2015 Nov; 20(11):1285-7. PubMed ID: 26365874
    [No Abstract]   [Full Text] [Related]  

  • 35. Magnetic resonance spectroscopy of cancer metabolism and response to therapy.
    McIntyre DJ; Madhu B; Lee SH; Griffiths JR
    Radiat Res; 2012 Apr; 177(4):398-435. PubMed ID: 22401303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using bioanalysis for cancer diagnosis and prognosis.
    Markuszewski MJ; Kaliszan R
    Bioanalysis; 2014 Apr; 6(7):907-9. PubMed ID: 24806899
    [No Abstract]   [Full Text] [Related]  

  • 37. Targeted therapy of cancer stem cells: science or fiction.
    Ogris M; Roidl A
    Ther Deliv; 2013 Feb; 4(2):135-8. PubMed ID: 23343151
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment-induced changes in the relationship between tumor and tumor host. Pathophysiological study of cancer chemotherapy, with special reference to lipid metabolism].
    Saito T
    Gan No Rinsho; 1969 Apr; 15(4):409-10. PubMed ID: 5817050
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cancer: when recycling becomes a weakness].
    Sonveaux P; Végran F; Verrax J; De Saedeleer CJ; Diepart C; Jordan BF; Gallez B; Feron O
    Med Sci (Paris); 2009 Apr; 25(4):327-9. PubMed ID: 19409177
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer robustness: tumour tactics.
    Kitano H
    Nature; 2003 Nov; 426(6963):125. PubMed ID: 14614483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.